Guggenheim Active Allocation Fund
 
 
 
 
基本資料
種類: ETF
費用比率%: 3.83
資產淨值: 16.56
成立日期: 23/11/2021
 
分析
市值分佈:
1.31%
大市值
0.77%
中市值
1.79%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/02/2026 05:42) 總持有投資項目: 528  
0%
 
100%
     10大 (2.26%)
代號 名稱 佔比% 持有日期
CARMCarisma Therapeutics, Inc.<0.000001%30/11/2025
CRISCuris<0.000001%30/11/2025
FBRXForte Biosciences Inc<0.000001%30/11/2025
FNCHFinch Therapeutics Group, Inc.<0.000001%30/11/2025
FRCBFirst Republic Bank (San Francisco, California)<0.000001%30/11/2025
FRCCLFirst Republic Bank (San Francisco, California)<0.000001%30/11/2025
FXLVF45 Training Holdings Inc.<0.000001%30/11/2025
GTBPGT Biopharma<0.000001%30/11/2025
HOOKHOOKIPA Pharma Inc.<0.000001%30/11/2025
IBIOiBio<0.000001%30/11/2025
IDEXQIdeanomics, Inc.<0.000001%30/11/2025
KALAKala BIO<0.000001%30/11/2025
KRROKorro Bio<0.000001%30/11/2025
PAVMPAVmed Inc<0.000001%30/11/2025
QTTBQ32 Bio<0.000001%30/11/2025
RVYLRyvyl Inc<0.000001%30/11/2025
SMSISmith Micro Software<0.000001%30/11/2025
SOPASociety Pass Incorporated<0.000001%30/11/2025
SQZBSQZ Biotechnologies Company<0.000001%30/11/2025
SRNESorrento Therapeutics, Inc.<0.000001%30/11/2025
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25   26    27  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.